Matica Enterprises Investor Dashboard

Company Overview:

Matica Enterprises is a Canadian publicly traded company focused on the Canadian Cannabis sector. Matica’s RoyalMax Biotechnology Canada Inc. has been granted a cultivation licence from Health Canada and is currently growing cannabis on Montreal’s west island. Matica is also building a 200,000 square foot greenhouse in the township of Hemmingford, just south of Montreal. Matica is planning for 1,000,000 square feet of greenhouses and for 25 acres of outdoor growing of cannabis on the 181 acre Hemmingford property. In addition to growing cannabis Matica is expanding into alternative cannabis delivery systems beginning with proprietary topicals creams using a mineral clay suspension technology which would provide a time released delivery. Recent developments in the regulation of cannabis have brought new opportunities to the Canadian marketplace and Matica will grow as the regulations unfold. .

[stock_market_chart symbol=”MMJ.CN” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]

Key Share Information:

Current Share Price$0.04
Market Capitalization (in Millions)$12.59
Last Quarter3/31/2019
Shares Outstanding (in Millions)314.65
Options (in Millions)30.15
Warrants (in Millions)5.62
Fully Diluted (in Millions)350.42

Enterprise Value (in Millions)$6.25
TTM Revenue$0.00
TTM Growth Margin %#DIV/0!
TTM Operating Expenses$7.35
TTM OCF$0.16
P/S TTM#DIV/0!
P/S (Last Quarter Run Rate)#DIV/0!

Key Balance Sheet Information (in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Cash$0.05$0.39$0.99$1.45$3.81$6.96$6.48$5.72$5.31$6.44
Biological Assets
Inventory$0.00
Total Assets$0.18$0.51$1.99$3.58$8.71$14.22$15.23$15.68$14.73$15.60
Net Tangible Assets$0.18$0.51$1.99$3.58$8.71$14.22$15.23$15.68$14.73$15.60
Intangibles/Goodwill
Total Liabilities$0.30$0.23$0.24$0.25$0.23$0.34$0.25$0.21$0.28$0.10

Key Operating Items (Quarterly in Millions $CAD):

 CYQ4'16CYQ1'17CYQ2'17CYQ3'17CYQ4'17CYQ1'18CYQ2'18CYQ3'18CYQ4'18CYQ1'19
Revenue
Change in Fair Value of Biologial Assets
Gross Margin
Marketing and Sales
Investor Relations$0.05$0.04$0.02$0.02$0.08$0.02$0.18$0.01$0.23$0.09
Total Operating Expenses$0.74$0.28$0.09$1.14$5.02$3.26$0.35$1.16$5.48$0.36
Operating Cash Flow (Quarterly)-$0.06$0.23-$0.07-$0.32-$0.22-$0.14-$0.07-$0.32$0.70
Investing Cash Flow (Quarterly)$0.07-$0.82-$1.16-$1.50-$1.65-$1.07-$0.76-$0.80$4.53
Financing Cash Flow (Quarterly)$0.32$1.20$1.69$4.19$5.02$0.72$0.07$0.72-$5.61

Listing Statement

All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.

Share
Tweet
Share